James Del Rosso, DO: New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab

from The Journal of Clinical and Aesthetic Dermatology · host JCAD

Send us Fan MailDr. Del Rosso discusses three exciting new indications for drugs in dermatology and how these approvals will impact clinical practice.

Episode metadata supplied by the publisher feed · Published Oct 18, 2024

Embed this episode

Attribution link and audio player

Ready to play

James Del Rosso, DO: New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab

0:00 7:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Journal of Clinical and Aesthetic Dermatology?

This episode is 7 minutes long.

When was this The Journal of Clinical and Aesthetic Dermatology episode published?

This episode was published on October 18, 2024.

Can I download this The Journal of Clinical and Aesthetic Dermatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!